A comprehensive view of Pregnancy Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
FDA grants Fast Track designation to J&J's nipocalimab injectable for FNAIT treatment, a potentially life-threatening condition affecting pregnant women's immune response to fetal platelets; it is the only therapy in clinical development for the disorder
Published:
March 26, 2024
by Janssen Pharmaceutical Companies
|
Janssen spearheads industry-relevant initiatives, from combatting maternal mortality disparities to promoting health equity in clinical research
Published:
March 15, 2024
by Industry Intelligence Inc.
|
Janssen Pharmaceutical Companies Advancing Inclusive Oncology Clinical Trials and Non-Surgical Solutions in Maternal-Fetal Immunology
Published:
February 15, 2024
by Industry Intelligence Inc.
|
Roche Prioritizes Prenatal Screening and Digital Health Innovations to Advance Patient Care and Clinical Research
Published:
February 14, 2024
by Industry Intelligence Inc.
|
Janssen Pharmaceutical's Breakthrough Designation Spearheads Vital Innovations in Maternal-Fetal Medicine
Published:
February 10, 2024
by Industry Intelligence Inc.
|
Ask us about our Government & Public Policy market view